SUSAN E SIEGEL
CIK 1240363 · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.27M
Companies
4
Total Filings
34
Lifetime Open-Market Net
-$538.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALGN | Director | 10,723 | $174.84 | $1.87M | -$538.8K | 15 | 2026-05-22 |
| ILMN | Director | 20,541 | $160.97 | $3.31M | $0 | 9 | 2026-05-22 |
| NEVRO CORP (NVRO) Delisted | Director | 0 | $5.84 | $0 | $0 | 6 | 2025-04-03 |
| PACB | Director | 65,000 | $1.31 | $85.2K | $0 | 3 | 2012-06-15 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-15 | PACB | Grant (A) | — | $0 | EDGAR |
| 2011-08-12 | PACB | Exer (M) | +65,000 | $45.5K | EDGAR |
| 2011-06-27 | PACB | Grant (A) | — | $0 | EDGAR |
| 2010-10-27 | — | Grant (A) | — | $0 |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.